Dr. Zumbado

13.1 Study Design. This phase 1 trial will use a design involving five parallel groups of patients with different degrees of renal dysfunction. The dose escalation rules used in this study, as detailed in Section 5.4.1, are adapted from the standard up-and-down “3&3” … ................
................